Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
This study is currently recruiting participants.
Study NCT00424203 Information provided by National Cancer Institute (NCI)
First Received: January 16, 2007 Last Updated: July 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Cognitive/Functional Effects
Depression
Malnutrition
Additional conditions recognized in this trial
Breast Neoplasms
Depressive Disorder
More general conditions related to this trial
Behavioral Symptoms
Breast Diseases
Mental Disorders
Mood Disorders
Neoplasms
Neoplasms by Site
Nutrition Disorders
Skin Diseases
Interventions listed in this trial
cyclophosphamide
doxorubicin hydrochloride
adjuvant therapy
cognitive assessment
management of therapy complications
psychosocial assessment and care
quality-of-life assessment
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
Doxorubicin
More general drug interventions related to this trial
Alkylating Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Federation Nationale des Centres de Lutte Contre le Cancer
Back to top of Main Content
